Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel DiseasePRNewsWire • 08/16/24
Is Eli Lilly Stock A Buy Or A Sell After Mounjaro And Zepbound Crush Expectations?Investors Business Daily • 08/15/24
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug marketCNBC • 08/14/24
Incretin Drug Class: Eli Lilly Likely A Big Beneficiary, As Are Many Other CompaniesSeeking Alpha • 08/14/24
Lilly, Uber among the biggest recent winners of the beat-and-raise game in the stock marketMarket Watch • 08/13/24
Wall Street Analysts See Lilly (LLY) as a Buy: Should You Invest?Zacks Investment Research • 08/13/24
Lilly opens state-of-the-art research and development center in the Boston SeaportPRNewsWire • 08/13/24
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health StockThe Motley Fool • 08/13/24
Why Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge RunThe Motley Fool • 08/13/24
Should Investors Buy Eli Lilly's (LLY) Stock After Strong Q2 Results?Zacks Investment Research • 08/12/24